Annual Total Long Term Liabilities
$20.26 M
-$6.23 M-23.51%
31 December 2023
Summary:
Scinai Immunotherapeutics annual total long term liabilities is currently $20.26 million, with the most recent change of -$6.23 million (-23.51%) on 31 December 2023. During the last 3 years, it has risen by +$17.99 million (+790.28%). SCNI annual total long term liabilities is now -56.65% below its all-time high of $46.74 million, reached on 01 December 2019.SCNI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$20.46 M
+$221.00 K+1.09%
30 June 2024
Summary:
Scinai Immunotherapeutics quarterly total long term liabilities is currently $20.46 million, with the most recent change of +$221.00 thousand (+1.09%) on 30 June 2024. Over the past year, it has increased by +$727.00 thousand (+3.68%). SCNI quarterly long term liabilities is now -56.22% below its all-time high of $46.74 million, reached on 01 December 2019.SCNI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCNI Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | +3.7% |
| 3 y3 years | +790.3% | +903.2% |
| 5 y5 years | -33.8% | -47.9% |
SCNI Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.2% | +790.3% | -28.5% | +903.2% |
| 5 y | 5 years | -56.6% | +790.3% | -56.2% | +903.2% |
| alltime | all time | -56.6% | >+9999.0% | -56.2% | >+9999.0% |
Scinai Immunotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $20.46 M(+1.1%) |
| Mar 2024 | - | $20.24 M(-0.1%) |
| Dec 2023 | $20.26 M(-23.5%) | $20.26 M(+2.7%) |
| Sept 2023 | - | $19.74 M(-21.4%) |
| June 2023 | - | $25.12 M(-1.6%) |
| Mar 2023 | - | $25.52 M(-3.6%) |
| Dec 2022 | $26.49 M(-7.4%) | $26.49 M(+57.1%) |
| Sept 2022 | - | $16.87 M(+1.7%) |
| June 2022 | - | $16.59 M(-25.6%) |
| Mar 2022 | - | $22.28 M(-22.1%) |
| Dec 2021 | $28.61 M(+1157.1%) | - |
| Dec 2021 | - | $28.61 M(+1302.7%) |
| Sept 2021 | - | $2.04 M(-8.7%) |
| June 2021 | - | $2.24 M(+3.5%) |
| Mar 2021 | - | $2.16 M(-5.1%) |
| Dec 2020 | $2.28 M(-95.1%) | $2.28 M(-88.0%) |
| Sept 2020 | - | $19.02 M(-53.6%) |
| June 2020 | - | $40.98 M(+1.4%) |
| Mar 2020 | - | $40.43 M(-13.5%) |
| Dec 2019 | $46.74 M | $46.74 M(+19.1%) |
| Sept 2019 | - | $39.24 M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $38.69 M(+24.5%) |
| Mar 2019 | - | $31.08 M(+1.6%) |
| Dec 2018 | $30.60 M(+473.1%) | $30.60 M(+74.0%) |
| Sept 2018 | - | $17.59 M(+53.0%) |
| June 2018 | - | $11.50 M(+95.5%) |
| Mar 2018 | - | $5.88 M(+10.1%) |
| Dec 2017 | $5.34 M(+558.6%) | $5.34 M(+58.3%) |
| Sept 2017 | - | $3.37 M(-35.7%) |
| June 2017 | - | $5.25 M(+74.1%) |
| Mar 2017 | - | $3.01 M(+271.8%) |
| Dec 2016 | $810.80 K(-47.8%) | $810.80 K(-15.5%) |
| Sept 2016 | - | $959.40 K(-25.9%) |
| June 2016 | - | $1.30 M(+6.2%) |
| Mar 2016 | - | $1.22 M(-21.5%) |
| Dec 2015 | $1.55 M(+9668.6%) | $1.55 M(-11.9%) |
| Sept 2015 | - | $1.76 M(-16.9%) |
| June 2015 | - | $2.12 M(>+9900.0%) |
| Mar 2015 | - | $16.20 K(+1.9%) |
| Dec 2014 | $15.90 K(+0.6%) | $15.90 K(-4.2%) |
| Sept 2014 | - | $16.60 K(+5.1%) |
| Dec 2013 | $15.80 K(+23.4%) | $15.80 K |
| Dec 2012 | $12.80 K | - |
FAQ
- What is Scinai Immunotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual total long term liabilities year-on-year change?
- What is Scinai Immunotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly long term liabilities year-on-year change?
What is Scinai Immunotherapeutics annual total long term liabilities?
The current annual total long term liabilities of SCNI is $20.26 M
What is the all time high annual total long term liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual total long term liabilities is $46.74 M
What is Scinai Immunotherapeutics annual total long term liabilities year-on-year change?
Over the past year, SCNI annual total long term liabilities has changed by -$6.23 M (-23.51%)
What is Scinai Immunotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SCNI is $20.46 M
What is the all time high quarterly long term liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly total long term liabilities is $46.74 M
What is Scinai Immunotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, SCNI quarterly total long term liabilities has changed by +$727.00 K (+3.68%)